EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

Laboratory testing of several imported unregistered melatonin products has confirmed them to be...

By targeting certain pain receptors in the bladder, Australian scientists believe that the...

Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...

Content from other channels on our network

$32 million investment to create jet fuel from forest waste

Australia's data centre future will be built on concrete — so make it more sustainable

WA wind farm to generate power for 100,000 homes

Ampd launches next-gen battery storage for heavy industries

Green hydrogen production receives boost using low-cost materials

ARENA backs aviation fuel from forestry byproducts

Transgrid to deploy synchronous condensers for NSW grid

BHP joins trial of lower‍-‍emissions copper supply chain tracking

ABB to modernise automation at Pelican Point Power Station

Government statement sets goals for Australia's space industry

Lactalis plans to close dairy factory in Gippsland, ADF comments

Frog peptide could increase the shelf life of strawberries

NZ food scientist recognised for impactful protein study

AIP appoints its new President

foodpro 2026 opens on Sunday